Why Cineplex (TSX:CGX) Stock Fell Over 20% This Week

Cineplex (TSX:CGX) stock plummeted when Cineworld announced it no longer intends to move forward with its planned acquisition.

| More on:
Arrow descending on a graph

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Stock in Canada’s largest movie theatre chain Cineplex (TSX:CGX) got hammered this week, falling as much as 23%. The stock tanked when U.K.-based movie theatre operator Cineworld announced it no longer intends to move forward with its planned acquisition.

Prior to the news, shares of the stock closed at $13.82 on Friday, June 12. But the announcement of the broken deal sent Cineplex shares plummeting. As of this writing, the stock is trading at $10.67.

Cracks were forming in the deal weeks ago

Late last year, Cineworld agreed to acquire Cineplex at $34 per share. Although Cineplex negotiated an option to solicit higher bids, no other bids were received.

The deal seemed destined to go through until movie theatres around the globe shut their doors due to the COVID-19 pandemic. In March, Cineworld announced it would close all 787 cinemas across 10 countries due to the coronavirus. Likewise, Cineplex indefinitely closed its 165 theatres across Canada.

Even before the pandemic, there were concerns about the debt required to seal the deal. The acquisition had already led Cineworld to take on additional financing of about $2.2 billion.

Soon after the pandemic began, cracks began to form in the deal. Cineworld reported that it was carefully monitoring the proposed buyout of Cineplex, as the company accessed emergency support programs to protect jobs and business.

The acquisition falls through

In announcing its plans to scrap the acquisition, Cineworld said in a statement, “As a consequence of … Cineplex’s unwillingness to cure the breaches, Cineworld has notified Cineplex that it has terminated the Arrangement Agreement with immediate effect.”

Cineworld did not specify what the breaches were, adding that a Material Adverse Effect occurred. A Material Adverse Effect is a common clause found in purchase agreements that could impact a deal’s closing. In legal terms, a Material Adverse Effect means any event, occurrence, fact, condition, or change that could reasonably be expected to become materially adverse to the business, such as results of operations, financial condition, assets, liabilities, or prospects.

Cineplex issued a separate statement denying the claims of Cineworld, adding that Cineworld’s allegations stem from the impact of the coronavirus outbreak. Cineworld argued that “The arrangement agreement explicitly excludes any “outbreaks of illness or other acts of God” from the definition of Material Adverse Effect.”

As expected, Cineplex promptly reported that it would begin legal proceedings and seek damages against its one-time suitor.

Cineplex plans to reopen

The news of the failed acquisition comes at the same time as Cineplex detailed plans of its gradual reopening across Canada. The reopening will begin with six locations in Alberta later this month.

As the COVID-19 restrictions across Canada begin to loosen, the chain hopes to reopen in as many other markets across the country, as government and health authorities allow, on July 3. Cineplex will introduce a number of new policies, including reserved seating in all auditoriums and staggered showtimes to reduce congestion in theatre lobbies.

The bottom line

No one can predict, even when theatres reopen, if the general public will feel comfortable being packed tightly into theatres due to lasting fears about a second wave of the coronavirus.

With the volatility in the stock, the failed acquisition, and the uncertainty surrounding moviegoers’ return to the theatres, I would hesitate to jump into this stock, even after its recent pullback.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Cindy Dye has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »